日本ケミファ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2019/11/22 | 日証協 | 26,342株 | -9.63% | 3,200株 | +255.56% | 56,386株 | -5.7% | 3,500株 | +5.93% |
2019/11/15 | 日証協 | 29,149株 | -4.89% | 900株 | -85.94% | 59,793株 | -5.37% | 3,304株 | -62.05% |
2019/11/08 | 日証協 | 30,649株 | +2% | 6,400株 | -19.46% | 63,188株 | +1.62% | 8,706株 | -53.15% |
2019/11/01 | 日証協 | 30,049株 | +17.65% | 7,946株 | +31.97% | 62,178株 | +15.28% | 18,581株 | +194.94% |
2019/10/25 | 日証協 | 25,542株 | +12.88% | 6,021株 | +1383% | 53,937株 | +2.08% | 6,300株 | +45.6% |
2019/10/18 | 日証協 | 22,627株 | +0.89% | 406株 | -20.7% | 52,837株 | -4.52% | 4,327株 | +13.99% |
2019/10/11 | 日証協 | 22,427株 | -1.75% | 512株 | -77.8% | 55,337株 | +0.91% | 3,796株 | +11.61% |
2019/10/04 | 日証協 | 22,827株 | -4.6% | 2,306株 | -11.72% | 54,837株 | -56% | 3,401株 | -94.44% |
2019/09/27 | 日証協 | 23,927株 | +6.69% | 2,612株 | -59.4% | 124,636株 | +2.13% | 61,126株 | +2893.44% |
2019/09/20 | 日証協 | 22,427株 | +12.55% | 6,433株 | +36.64% | 122,036株 | -2.94% | 2,042株 | -76.95% |
2019/09/13 | 日証協 | 19,927株 | -1% | 4,708株 | +176.94% | 125,734株 | +2.89% | 8,858株 | +88.47% |
2019/09/06 | 日証協 | 20,128株 | +6.26% | 1,700株 | +20.31% | 122,207株 | +21.19% | 4,700株 | -78.65% |
2019/08/30 | 日証協 | 18,943株 | -3.56% | 1,413株 | +895.07% | 100,839株 | -13.71% | 22,010株 | +22.95% |
2019/08/23 | 日証協 | 19,642株 | -0.87% | 142株 | -64.5% | 116,867株 | +16.24% | 17,901株 | +1390.51% |
2019/08/16 | 日証協 | 19,815株 | +0.08% | 400株 | -78.2% | 100,539株 | +28.93% | 1,201株 | -98.05% |
2019/08/09 | 日証協 | 19,800株 | -10.81% | 1,835株 | -38.83% | 77,980株 | +39.89% | 61,472株 | +778.17% |
2019/08/02 | 日証協 | 22,199株 | +26.14% | 3,000株 | -28.57% | 55,743株 | +1.77% | 7,000株 | +100% |
2019/07/26 | 日証協 | 17,599株 | +15.79% | 4,200株 | 0% | 54,771株 | +2.05% | 3,500株 | +399.29% |
2019/07/19 | 日証協 | 15,199株 | -0.65% | 0株 | -100% | 53,671株 | 0% | 701株 | -64.95% |
※株式分割は考慮していませんのでご注意ください。